Athelas

Healthcare technology solutions for medical efficiency

Mountain View, California, United States

About Athelas

Athelas enhances efficiency in medical practices by providing healthcare technology solutions. Its main product simplifies the blood draw process for clozapine patients, delivering laboratory-accurate results in minutes at the point of care. This approach reduces the time and effort associated with traditional blood draws. Additionally, Athelas offers 'Scribe,' a tool that minimizes documentation time for healthcare professionals, allowing them to focus more on patient care. Unlike many competitors, Athelas specifically targets the needs of healthcare providers by streamlining processes and improving patient experiences. The company's goal is to optimize healthcare delivery, making it more efficient and effective for both providers and patients.

Mountain View, CaliforniaHeadquarters
2016Year Founded
$151.9MTotal Funding
SERIES_BCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Risks

Integration challenges with Commure's systems could delay merger benefits.
Rapid expansion may lead to operational inefficiencies, impacting service quality.
Reliance on FDA clearance poses risks if future products face regulatory hurdles.

Differentiation

Athelas offers FDA-cleared blood diagnostic devices for home use, enhancing patient convenience.
The company provides a unique solution for clozapine patients, simplifying blood draw regimens.
Athelas' Scribe tool reduces documentation time, improving patient care and clinical decisions.

Upsides

The merger with Commure creates a $6B healthcare infrastructure company, expanding market reach.
Athelas' remote patient monitoring platform is the fastest-growing in the U.S.
Rising demand for home-based healthcare solutions supports Athelas' business model.